Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:36 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 1,738 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Study Device Arm Clear all

Conditions: Resistant Hypertension
Interventions: HyperQureTM Renal Denervation (RDN) System:; Device
Lead sponsor: DeepQure Inc.; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 6
States / cities: Orange, California • Stanford, California • Gainesville, Florida + 3 more

Conditions: Post-Acute COVID-19 Syndrome, Cognitive Dysfunction
Interventions: Pascal device, Sham Device; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke
Interventions: Hand & Wrist Assisting Robotic Device; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Irvine, California

Conditions: Lymphedema, Secondary, Lymphedema of Upper Limb
Interventions: PhysioTouch, Manual Lymph Drainage (MLD); Device · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Intracranial Aneurysms
Interventions: Low profile Visualized Intraluminal Device (LVIS and LVIS Jr.); Device
Lead sponsor: Microvention-Terumo, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 6
States / cities: Albany, New York • Stony Brook, New York • Philadelphia, Pennsylvania + 3 more

Conditions: High Risk for Postoperative Cardiovascular Events
Interventions: endothelial function testing; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 50 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Alcohol Use Disorder, Liver Diseases
Interventions: DALC Digital Clinic; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Scottsdale, Arizona • Rochester, Minnesota

Conditions: Low Back Pain
Interventions: Continuous Passive Motion; Device
Lead sponsor: Radiancy; Industry
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Peripheral Arterial Disease
Interventions: Intravascular Lithotripsy; Device
Lead sponsor: Shockwave Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 21
States / cities: Palo Alto, California • Thornton, Colorado • Bradenton, Florida + 18 more

Conditions: Osteoarthritis Shoulder, Avascular Necrosis of the Head of Humerus, Rheumatoid Arthritis Shoulder
Interventions: Catalyst CSR Total Shoulder System; Device
Lead sponsor: Catalyst OrthoScience; Industry
Eligibility: 18 Years and older
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 3
States / cities: Royal Oak, Michigan • Portland, Oregon • Providence, Rhode Island

Conditions: Refractory Ventricular Tachycardia
Interventions: Saline Enhanced Radiofrequency (SERF) Ablation; Device
Lead sponsor: Thermedical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 5
States / cities: Birmingham, Alabama • Philadelphia, Pennsylvania • Charleston, South Carolina + 2 more

Conditions: SAH (Subarachnoid Hemorrhage), Headache
Interventions: Transnasal sphenopalatine ganglion block; Combination Product
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 100 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Prostate Cancer
Interventions: TRUS-RALRP; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 35 Years to 75 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Aortic Dissection Type B
Interventions: Relay Pro Stent-Graft; Device
Lead sponsor: Bolton Medical; Industry
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 21
States / cities: Los Angeles, California • Aurora, Colorado • Hartford, Connecticut + 17 more

Conditions: Systolic Heart Failure, Atrial Fibrillation (Permanent)
Interventions: Atrioventricular junctional (AVJ) ablation, Cardiac resynchronization therapy - defibrillator; Procedure · Device
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 21
States / cities: Little Rock, Arkansas • Pasadena, California • Atlanta, Georgia + 16 more

Conditions: Glucose, Low Blood, Glucose, High Blood
Interventions: Dose Safety AP system; Device
Lead sponsor: Dose Safety Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Redmond, Washington

Conditions: Artificial Intelligence (AI), Physician Burnout, Physician Work Environment
Interventions: Use of Ambient AI scribe tool on participant's mobile device; Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Coronary Artery Disease
Interventions: Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System; Device
Lead sponsor: Teleflex; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 10
States / cities: Concord, California • Wichita, Kansas • Boston, Massachusetts + 7 more

Conditions: Pain
Interventions: Ethyl Chloride Topical Aerosol Anesthetic, Nature's Tears Sterile Water; Drug
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Peripheral Arterial Disease, Peripheral Vascular Diseases, Arterial Occlusive Diseases
Interventions: PTA (UltraScore Focused Force PTA Balloon); Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 21 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 31
States / cities: Phoenix, Arizona • Denver, Colorado • Miami Beach, Florida + 27 more

Conditions: Coronary Arterial Disease (CAD)
Interventions: Intravascular Lithotripsy; Device
Lead sponsor: Shockwave Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 408 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 28
States / cities: La Jolla, California • San Francisco, California • Littleton, Colorado + 19 more

Conditions: Tricuspid Valve Regurgitation, Tricuspid Valve Disease, Cardiovascular Diseases (CVD), Heart Valve Diseases, Tricuspid Valve Insufficiency, Severe Heart Valve Disease, Randomized Controlled Trial (RCT), Symptomatic Tricuspid Regurgitation
Interventions: Transcatheter Tricuspid Valve Replacement (TTVR) with VDyne System, Transcatheter Tricuspid Valve Replacement (TTVR) with Edwards EVOQUE System; Device
Lead sponsor: VDyne, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 730 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2036
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pregnancy, Sleep
Interventions: Misfit Shine 2; Behavioral
Lead sponsor: University of Massachusetts, Amherst; Other
Eligibility: 18 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Amherst, Massachusetts

Conditions: Type2Diabetes, Pregnancy in Diabetic
Interventions: Dexcom G6 CGM, Participant Finger Stick Glucose Monitoring; Device · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Search by objective public record fields.

Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension

Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction

Robot-Assisted Hand Motor Therapy for Subjects With Hemiparetic Stroke

Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device

Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device

Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events

Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)

The Efficacy of the Kyrobak for Chronic Low Back Pain (LBP-2)

FORWARD PAD IDE Study With the Shockwave Javelin IVL Catheter

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty

Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT

Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache

Transrectal Ultrasound Imaging of the Prostate Gland and Neurovascular Bundles During Robot-Assisted Laparoscopic Radical Prostatectomy

Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection

Junctional AV Ablation in CRT-D: JAVA-CRT

Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC

Ambient AI Clinical Trial

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

Skin Refrigerant to Reduce the Pain Associated With IV Insertion

Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon

FORWARD CAD IDE Study

VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)

Sleep Self-management in Pregnancy Using a Personalized Health Monitoring Device

AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy